GAMA
Graticule Asia Macro Advisors Portfolio holdings
AUM
$274M
This Quarter Return
-1.97%
1 Year Return
+20.12%
3 Year Return
+142.11%
5 Year Return
+186.51%
10 Year Return
–
AUM
$404M
AUM Growth
+$404M
(-38%)
Cap. Flow
-$233M
Cap. Flow
% of AUM
-57.53%
Top 10 Holdings %
Top 10 Hldgs %
65.42%
Holding
116
New
41
Increased
15
Reduced
14
Closed
29
Top Buys
| 1 |
Eli Lilly
LLY
|
$20.5M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$12.6M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
$9M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$8.98M |
| 5 |
iShares China Large-Cap ETF
FXI
|
$7.41M |
Top Sells
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$34.1M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
$31M |
| 3 |
Amazon
AMZN
|
$29.7M |
| 4 |
Apple
AAPL
|
$27M |
| 5 |
Illumina
ILMN
|
$20.5M |
Sector Composition
| 1 | Healthcare | 20.06% |
| 2 | Consumer Discretionary | 12.34% |
| 3 | Communication Services | 10.05% |
| 4 | Financials | 6.39% |
| 5 | Industrials | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares 7-10 Year Treasury Bond ETF
IEF
$35.7B
| $113M | 13.18% |
1,048,000
-287,000
| -21% | -$31M |
|
|
2
Amazon
AMZN
$2.44T
| $33.9M | 3.95% |
66,200
-58,010
| -47% | -$29.7M |
|
|
3
Eli Lilly
LLY
$657B
| $20.5M | 2.39% |
+244,600
| New | +$20.5M |
|
|
4
Alphabet (Google) Class C
GOOG
$2.58T
| $20.4M | 2.38% |
31,962
+14,062
| +79% | +$8.98M |
|
|
JUNO
5
DELISTED
Juno Therapeutics, Inc.
JUNO
| $17.7M | 2.06% |
435,205
+308,705
| +244% | +$12.6M |
|
6
Trip.com Group
TCOM
$48.2B
| $14.8M | 1.72% |
234,000
+107,800
| +85% | +$6.81M |
|
|
7
iShares China Large-Cap ETF
FXI
$6.65B
| $13.1M | 1.53% |
369,000
+209,029
| +131% | +$7.41M |
|
|
NEWR
8
DELISTED
New Relic, Inc.
NEWR
| $12.4M | 1.44% |
325,100
+236,100
| +265% | +$9M |
|
9
American International
AIG
$45.1B
| $11.7M | 1.36% |
206,000
-169,900
| -45% | -$9.65M |
|
10
Meta Platforms (Facebook)
META
$1.86T
| $6.99M | 0.81% |
77,700
+16,700
| +27% | +$1.5M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.55M | 0.76% |
+41,900
| New | +$6.55M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.97M | 0.7% |
56,700
+8,700
| +18% | +$916K |
|
13
Regenxbio
RGNX
$451M
| $5.91M | 0.69% |
+268,000
| New | +$5.91M |
|
14
Incyte
INCY
$16.5B
| $5.8M | 0.68% |
52,600
-40,282
| -43% | -$4.44M |
|
15
Ultragenyx Pharmaceutical
RARE
$2.89B
| $5.6M | 0.65% |
+58,100
| New | +$5.6M |
|
|
IRS
16
IRSA Inversiones y Representaciones
IRS
$1.11B
| $5.56M | 0.65% |
382,107
+7,700
| +2% | +$112K |
|
17
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$2.34B
| $4.85M | 0.57% |
150,000
+35,000
| +30% | +$1.13M |
|
18
Pampa Energía
PAM
$3.67B
| $4.6M | 0.54% |
301,157
+34,100
| +13% | +$521K |
|
19
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.5B
| $4.56M | 0.53% |
+39,300
| New | +$4.56M |
|
20
Freeport-McMoran
FCX
$63.7B
| $4.46M | 0.52% |
+460,000
| New | +$4.46M |
|
21
AXIS Capital
AXS
$7.71B
| $4.45M | 0.52% |
+82,886
| New | +$4.45M |
|
|
ADXS
22
DELISTED
Advaxis, Inc.
ADXS
| $4.43M | 0.52% |
432,873
+99,999
| +30% | +$1.02M |
|
23
Walt Disney
DIS
$213B
| $4.38M | 0.51% |
+42,900
| New | +$4.38M |
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $4.24M | 0.49% |
+106,500
| New | +$4.24M |
|
25
CME Group
CME
$96B
| $4.17M | 0.49% |
+45,000
| New | +$4.17M |
|